Literature DB >> 22138692

Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder.

Josephine Elia1, Joseph T Glessner, Kai Wang, Nagahide Takahashi, Corina J Shtir, Dexter Hadley, Patrick M A Sleiman, Haitao Zhang, Cecilia E Kim, Reid Robison, Gholson J Lyon, James H Flory, Jonathan P Bradfield, Marcin Imielinski, Cuiping Hou, Edward C Frackelton, Rosetta M Chiavacci, Takeshi Sakurai, Cara Rabin, Frank A Middleton, Kelly A Thomas, Maria Garris, Frank Mentch, Christine M Freitag, Hans-Christoph Steinhausen, Alexandre A Todorov, Andreas Reif, Aribert Rothenberger, Barbara Franke, Eric O Mick, Herbert Roeyers, Jan Buitelaar, Klaus-Peter Lesch, Tobias Banaschewski, Richard P Ebstein, Fernando Mulas, Robert D Oades, Joseph Sergeant, Edmund Sonuga-Barke, Tobias J Renner, Marcel Romanos, Jasmin Romanos, Andreas Warnke, Susanne Walitza, Jobst Meyer, Haukur Pálmason, Christiane Seitz, Sandra K Loo, Susan L Smalley, Joseph Biederman, Lindsey Kent, Philip Asherson, Richard J L Anney, J William Gaynor, Philip Shaw, Marcella Devoto, Peter S White, Struan F A Grant, Joseph D Buxbaum, Judith L Rapoport, Nigel M Williams, Stanley F Nelson, Stephen V Faraone, Hakon Hakonarson.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common, heritable neuropsychiatric disorder of unknown etiology. We performed a whole-genome copy number variation (CNV) study on 1,013 cases with ADHD and 4,105 healthy children of European ancestry using 550,000 SNPs. We evaluated statistically significant findings in multiple independent cohorts, with a total of 2,493 cases with ADHD and 9,222 controls of European ancestry, using matched platforms. CNVs affecting metabotropic glutamate receptor genes were enriched across all cohorts (P = 2.1 × 10(-9)). We saw GRM5 (encoding glutamate receptor, metabotropic 5) deletions in ten cases and one control (P = 1.36 × 10(-6)). We saw GRM7 deletions in six cases, and we saw GRM8 deletions in eight cases and no controls. GRM1 was duplicated in eight cases. We experimentally validated the observed variants using quantitative RT-PCR. A gene network analysis showed that genes interacting with the genes in the GRM family are enriched for CNVs in ∼10% of the cases (P = 4.38 × 10(-10)) after correction for occurrence in the controls. We identified rare recurrent CNVs affecting glutamatergic neurotransmission genes that were overrepresented in multiple ADHD cohorts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138692      PMCID: PMC4310555          DOI: 10.1038/ng.1013

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  57 in total

1.  Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7.

Authors:  John F Cryan; Peter H Kelly; Hans C Neijt; Gilles Sansig; Peter J Flor; Herman van Der Putten
Journal:  Eur J Neurosci       Date:  2003-06       Impact factor: 3.386

2.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

Review 3.  Pharmacology and functions of metabotropic glutamate receptors.

Authors:  P J Conn; J P Pin
Journal:  Annu Rev Pharmacol Toxicol       Date:  1997       Impact factor: 13.820

4.  Effects of neonatal 6-hydroxydopamine lesion on the gene expression profile in young adult rats.

Authors:  Yoshinori Masuo; Masami Ishido; Masatoshi Morita; Syuichi Oka
Journal:  Neurosci Lett       Date:  2002-12-25       Impact factor: 3.046

5.  Human metabotropic glutamate receptor type 7: molecular cloning and mRNA distribution in the CNS.

Authors:  A Makoff; C Pilling; K Harrington; P Emson
Journal:  Brain Res Mol Brain Res       Date:  1996-08

6.  Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study.

Authors:  Normand Carrey; Frank P MacMaster; Joshua Fogel; Sandra Sparkes; Dan Waschbusch; Sara Sullivan; Mathias Schmidt
Journal:  Clin Neuropharmacol       Date:  2003 Jul-Aug       Impact factor: 1.592

7.  Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder.

Authors:  Frank P MacMaster; Normand Carrey; Sandra Sparkes; Vivek Kusumakar
Journal:  Biol Psychiatry       Date:  2003-01-15       Impact factor: 13.382

8.  Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings.

Authors:  Helen Courvoisie; Stephen R Hooper; Camille Fine; Lester Kwock; Mauricio Castillo
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2004       Impact factor: 2.198

9.  Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD.

Authors:  D Turic; K Langley; S Mills; M Stephens; D Lawson; C Govan; N Williams; M Van Den Bree; N Craddock; L Kent; M Owen; M O'Donovan; A Thapar
Journal:  Mol Psychiatry       Date:  2004-02       Impact factor: 15.992

Review 10.  Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder--the spontaneously hypertensive rat.

Authors:  Vivienne Ann Russell
Journal:  Neurosci Biobehav Rev       Date:  2003-11       Impact factor: 8.989

View more
  129 in total

Review 1.  CNVs: harbingers of a rare variant revolution in psychiatric genetics.

Authors:  Dheeraj Malhotra; Jonathan Sebat
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 2.  Genetics in child and adolescent psychiatry: methodological advances and conceptual issues.

Authors:  Sarah Hohmann; Nicoletta Adamo; Benjamin B Lahey; Stephen V Faraone; Tobias Banaschewski
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-04-08       Impact factor: 4.785

3.  A null mutation in TNIK defines a novel locus for intellectual disability.

Authors:  Shams Anazi; Hanan E Shamseldin; Dhekra AlNaqeb; Mohamed Abouelhoda; Dorota Monies; Mustafa A Salih; Khalid Al-Rubeaan; Fowzan S Alkuraya
Journal:  Hum Genet       Date:  2016-04-22       Impact factor: 4.132

Review 4.  Prefrontal cortex executive processes affected by stress in health and disease.

Authors:  Milena Girotti; Samantha M Adler; Sarah E Bulin; Elizabeth A Fucich; Denisse Paredes; David A Morilak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-07-06       Impact factor: 5.067

Review 5.  Fifty Years of Research in ARDS. Genomic Contributions and Opportunities.

Authors:  John P Reilly; Jason D Christie; Nuala J Meyer
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

6.  Impact of autism-associated genetic variants in interaction with environmental factors on ADHD comorbidities: an exploratory pilot study.

Authors:  Regina Waltes; Christine M Freitag; Timo Herlt; Thomas Lempp; Christiane Seitz; Haukur Palmason; Jobst Meyer; Andreas G Chiocchetti
Journal:  J Neural Transm (Vienna)       Date:  2019-11-09       Impact factor: 3.575

7.  Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy.

Authors:  Dana Marafi; Tadahiro Mitani; Sedat Isikay; Jozef Hertecant; Mohammed Almannai; Kandamurugu Manickam; Rami Abou Jamra; Ayman W El-Hattab; Jaishen Rajah; Jawid M Fatih; Haowei Du; Ender Karaca; Yavuz Bayram; Jaya Punetha; Jill A Rosenfeld; Shalini N Jhangiani; Eric Boerwinkle; Zeynep C Akdemir; Serkan Erdin; Jill V Hunter; Richard A Gibbs; Davut Pehlivan; Jennifer E Posey; James R Lupski
Journal:  Ann Clin Transl Neurol       Date:  2020-04-14       Impact factor: 4.511

8.  Phenotypic profiling of mGlu7 knockout mice reveals new implications for neurodevelopmental disorders.

Authors:  Nicole M Fisher; Robert W Gould; Rocco G Gogliotti; Annalise J McDonald; Hana Badivuku; Susmita Chennareddy; Aditi B Buch; Annah M Moore; Matthew T Jenkins; W Hudson Robb; Craig W Lindsley; Carrie K Jones; P Jeffrey Conn; Colleen M Niswender
Journal:  Genes Brain Behav       Date:  2020-04-14       Impact factor: 3.449

Review 9.  Attention-deficit/hyperactivity disorder genomics: update for clinicians.

Authors:  Josephine Elia; Jillan Sackett; Terri Turner; Martin Schardt; Shih-Ching Tang; Nicole Kurtz; Maura Dunfey; Nadia A McFarlane; Aita Susi; David Danish; Alice Li; Jenelle Nissley-Tsiopinis; Karin Borgmann-Winter
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

Review 10.  Confluence of genes, environment, development, and behavior in a post Genome-Wide Association Study world.

Authors:  Scott I Vrieze; William G Iacono; Matt McGue
Journal:  Dev Psychopathol       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.